Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.77 +0.04 (+1.01%)
As of: Sep 30, 2026 · 10:25 AM EDT

Whitehawk Therapeutics (WHWK) Research & Development (2016 - 2026)

Updated

Whitehawk Therapeutics (WHWK) posted Research & Development of $12.89 million for Q2 2026, down 73.6% from $48.81 million a year earlier and down 25.2% from the prior quarter.

Analysis

Whitehawk Therapeutics (WHWK) Research & Development (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Whitehawk Therapeutics was $63.49 million, down 22.5% year-over-year; for FY2025, it came in at $90.96 million, up 78.3% from FY2024.

  • Annual Research & Development has increased for six consecutive years, with a five-year compound annual growth rate of 43.4% (FY2020 to FY2025).
  • In prior years, Whitehawk Therapeutics' Research & Development was $51.03 million in FY2024 (+4.3%), $48.93 million in FY2023 (+49.8%), $32.66 million in FY2022 (+66.0%) and $19.67 million in FY2021 (+31.1%).
  • The Q2 2026 figure stands as the lowest quarterly Research & Development since Q1 2025.
  • On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 41.6%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q2 2025, with growth of 272.8%; the weakest was Q2 2026, with a decline of 73.6%.
  • According to Business Quant data, Research & Development for the three prior quarters was $17.23 million (Q1 2026), $19.02 million (Q4 2025) and $14.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Whitehawk Therapeutics 311.65 Mn 311.65 Mn - 12.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.89 Mn
Mar 31, 2026 17.23 Mn
Dec 31, 2025 19.02 Mn
Sep 30, 2025 14.35 Mn
Jun 30, 2025 48.81 Mn
Mar 31, 2025 8.79 Mn
Dec 31, 2024 14.35 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 13.09 Mn
Mar 31, 2024 13.59 Mn
Dec 31, 2023 12.77 Mn
Sep 30, 2023 11.89 Mn
Jun 30, 2023 13.32 Mn
Mar 31, 2023 10.96 Mn
Dec 31, 2022 9.37 Mn
Sep 30, 2022 8.77 Mn
Jun 30, 2022 7.73 Mn
Mar 31, 2022 6.79 Mn
Dec 31, 2021 7.23 Mn
Sep 30, 2021 5.75 Mn
API Access

Whitehawk Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=WHWK&period=max&api_key=YOUR_API_KEY